<html>

    <head>
  <meta charset="utf-8">
  <title>Disease phenotype prediction in multiple sclerosis | pharmb.io - Pharmaceutical Bioinformatics Research Group at Uppsala University</title>
  <meta content="width=device-width, initial-scale=1" name="viewport">
  <meta content="Webflow" name="generator">
  <link href="/css/normalize.css" rel="stylesheet" type="text/css">
  <link href="/css/webflow.css" rel="stylesheet" type="text/css">
  <link href="/css/pharmbio.webflow.css?1704661933" rel="stylesheet" type="text/css">
  <script src="https://ajax.googleapis.com/ajax/libs/webfont/1.4.7/webfont.js"></script>
  <script type="text/javascript">
    WebFont.load({
      google: {
        families: ["Ubuntu:300,300italic,400,400italic,500,500italic,700,700italic","Raleway:regular,500,600,700,800,900"]
      }
    });
  </script>
  <script src="/js/modernizr.js" type="text/javascript"></script>
  <link href="/img/pharmbio_logo_square_64x64.png" rel="shortcut icon" type="image/x-icon">
  <link href="/img/pharmbio_logo_square_64x64.png" rel="apple-touch-icon">
  <script>
    (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
    (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
    m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
    })(window,document,'script','https://www.google-analytics.com/analytics.js','ga');

    ga('create', 'UA-86146183-1', 'auto');
    ga('send', 'pageview');
  </script>
</head>


    
  <div class="section-header" id="section-header">
    <div class="section-header-container w-container">
      <div class="navbar w-nav" data-animation="default" data-collapse="medium" data-contain="1" data-doc-height="1" data-duration="400" data-no-scroll="1">
        <div class="navbar-container w-container">
          <a class="navbar-brand w-nav-brand" href="/">
              <img class="navbar-logo" src="/img/pharmbio-logo-new.png">
          </a>
          <div class="navbar-menubutton w-nav-button">
            <div class="w-icon-nav-menu"></div>
          </div>
          <a class="navbar-uulogo-link" href="http://farmbio.uu.se/forskning/researchgroups/pb/Data-intensive/" target="_blank"><img class="navbar-uulogo-img" src="/img/uulogo_64x64.png"></a>
          <nav class="navbar-menu w-nav-menu" role="navigation" style="float: right">
              
              <a class="navbar-link w-nav-link" href="/project/">Projects</a>
              
              <a class="navbar-link w-nav-link" href="/people/">People</a>
              
              <a class="navbar-link w-nav-link" href="/infrastructure/">Infrastructure</a>
              
              <a class="navbar-link w-nav-link" href="/publication/">Publications</a>
              
              
              
              <a class="navbar-link w-nav-link" href="/tool/">Tools</a>
              
              <a class="navbar-link w-nav-link" href="/education/">Education</a>
              
              <a class="navbar-link w-nav-link" href="/about/">About</a>
              
              
              
              
              
              
              
          </nav>
        </div>
      </div>
    </div>
  </div>

              <div>
          <div class="section-content-container w-container content">

        <h1 style="font-size: 1.4em">Disease phenotype prediction in multiple sclerosis</h1>
        <p><a href="/publication">&larr; Back to publications</a></p>

        <p>Published: 2023-06-09</p>

        <h4>Formatted citation</h4>
        <p>
            Herman S, Arvidsson McShane S, Zhukovsky C, Khoonsari PE, Svenningsson A, Burman J, Spjuth O, Kultima K..
            <a href="http://dx.doi.org/10.1016/j.isci.2023.106906" target="_blank">Disease phenotype prediction in multiple sclerosis</a>.
            <br><em>iScience</em>.
            <strong>26</strong>, 6 (2023).
            DOI: <a href="http://dx.doi.org/10.1016/j.isci.2023.106906" target="_blank">10.1016/j.isci.2023.106906</a>
            
        </p>
        <h4>Abstract</h4>
        <p>Progressive multiple sclerosis (PMS) is currently diagnosed retrospectively. Here, we investigated an alternative route to the diagnosis. A selection of cerebrospinal fluid metabolites (n=15) were shown to be able to distinguish PMS from relapsing-remitting MS (AUC=0.93) in a validation cohort. Conformal prediction models showed that, at a 94% confidence level, 88% of patients could be correctly predicted, and four out of eight patients that developed PMS within three years were predicted as PMS. The methodology was further applied to PMS patients in a clinical trial where traditional endpoints were largely inconclusive. The methodology showed that 68% of the patients decreased their similarity to the PMS phenotype one year after treatment. Also on a group-level, a significant (P&lt;0.01) biochemical effect could be seen. This conceptual work demonstrates a methodology that may be useful in monitoring disease progression and as an endpoint in future trials. Finally, 4-acetamidobutanoate showed significant associations to several clinical measures, further strengthening the evidence of its relation to MS.</p>

            </div>
</div>

      <div class="section-footer">
    <div class="section-footer-container w-container">
        
        <div class="footer-text">
            <p>
            <strong>Pharmaceutical Bioinformatics Research Group</strong><br>
            Department of Pharmaceutical Biosciences<br>
            Uppsala University, Sweden<br>
            GitHub: <a href="https://github.com/pharmbio">github.com/pharmbio</a>
            </p>
        </div>
    </div>
  </div>

  <script src="https://ajax.googleapis.com/ajax/libs/jquery/2.2.0/jquery.min.js" type="text/javascript"></script>
  <script src="/js/webflow.js" type="text/javascript"></script>
  
</body>
</html>

